Lumiliximab is an IgG1k monoclonal antibody that targets CD23. It acts as an immunomodulator and was awarded orphan drug status and fast track designation...
4 KB (284 words) - 14:18, 5 January 2024
(+hyaluronidase) Pascolizumab Rituximab Ublituximab CD23 Gomiliximab Lumiliximab CD40 Teneliximab Toralizumab CD62L/L-selectin Aselizumab CD80 Galiximab...
7 KB (299 words) - 13:45, 27 April 2024
(INN) Lufyllin luliconazole (USAN) lumefantrine (INN) Lumenhance Lumigan lumiliximab (INN) lumiracoxib (USAN) Lumisight Lumryz lunacalcipol (INN) Lunelle...
3 KB (218 words) - 20:57, 27 August 2024
Hodgkin's lymphoma Lulizumab pegol mab humanized CD28 autoimmune diseases Lumiliximab mab chimeric CD23 (IgE receptor) chronic lymphocytic leukemia Lumretuzumab...
137 KB (4,083 words) - 21:25, 19 October 2024
C2115H3252N556O673S16 (molar mass: 47,750 g/mol) may refer to: Certolizumab pegol Lumiliximab This set index page lists chemical structure articles associated with...
357 bytes (50 words) - 14:05, 3 May 2022
Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab Vapaliximab Humanized Immunosuppressive: Apolizumab§...
38 KB (4,316 words) - 10:24, 26 August 2024
Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab Vapaliximab Humanized Immunosuppressive: Apolizumab§...
2 KB (87 words) - 01:28, 30 May 2023
their attached radioactive isotopes to and kill CD20-bearing cells; lumiliximab, a monoclonal antibody that binds to CD23; dacetuzumab, a monoclonal...
22 KB (2,669 words) - 05:05, 4 January 2024
(+hyaluronidase) Pascolizumab Rituximab Ublituximab CD23 Gomiliximab Lumiliximab CD40 Teneliximab Toralizumab CD62L/L-selectin Aselizumab CD80 Galiximab...
38 KB (2,656 words) - 12:11, 30 October 2023